Ephraim Heller is a well-recognized entrepreneur and investor in the healthcare industry. He completed a degree in Physics at Harvard University and later pursued a Master's in Business Administration (MBA) from the prestigious Yale School of Management. With extensive experience in biomedical engineering, he has co-founded and led several healthcare companies, including SynAgile Corporation, AngioScore, and TheraSense Inc. His professional career spans over two decades, during which he held several important positions such as CEO, Chairman, and Venture Partner.

Heller has also served on the board of Nitrome Biosciences and IntelliDx. He has a keen interest in technological advancements that improve the accuracy of patient diagnostics and treatment, and he has been shaping the healthcare industry with his innovative ideas.